Shengnan Li
- Epidemiology
- Molecular Biology
- Pharmacology top 5%
- Hepatology top 5%
- Complementary and alternative medicine top 5%
- Co-authors
- Yongfang YuanRong WangYanqiu GuFuxing SongBin WuJing WangPanpan ChenYuanyuan Wang
- Topics
- Liver physiology and pathology (11 papers)Liver Disease Diagnosis and Treatment (10 papers)Drug-Induced Hepatotoxicity and Protection (9 papers)
- Journals
- Proceedings of the National Academy of SciencesSHILAP Revista de lepidopterologíaScientific Reports
- Partner nations
- ChinaMalaysiaBangladesh
In The Last Decade
Shengnan Li
28 papers receiving 704 citations
Peers
Comparison fields: 5 of 97
- Epidemiology 243
- Molecular Biology 230
- Pharmacology 140
- Hepatology 132
- Complementary and alternative medicine 76
Countries citing papers authored by Shengnan Li
This map shows the geographic impact of Shengnan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengnan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengnan Li more than expected).
Fields of papers citing papers by Shengnan Li
This network shows the impact of papers produced by Shengnan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengnan Li. The network helps show where Shengnan Li may publish in the future.
Co-authorship network of co-authors of Shengnan Li
This figure shows the co-authorship network connecting the top 25 collaborators of Shengnan Li. A scholar is included among the top collaborators of Shengnan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengnan Li. Shengnan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 2 | |
| 7 | 15 | |
| 8 | 10 | |
| 9 | 7 | |
| 10 | 24 | |
| 11 | 36 | |
| 12 | 16 | |
| 13 | 1 | |
| 14 | 41 | |
| 15 | 90 | |
| 16 | 19 | |
| 17 | 40 | |
| 18 | 13 | |
| 19 | 66 | |
| 20 | 67 |
About Shengnan Li
Shengnan Li is a scholar working on Hepatology, Pharmacology and Epidemiology, having authored 33 papers that have together received 709 indexed citations. Recurring topics across this work include Liver physiology and pathology (11 papers), Liver Disease Diagnosis and Treatment (10 papers) and Drug-Induced Hepatotoxicity and Protection (9 papers). The work is most often cited by research in Hepatology (132 citations), Pharmacology (140 citations) and Complementary and alternative medicine (76 citations). Shengnan Li has collaborated with scholars based in China, Malaysia and Bangladesh. Frequent co-authors include Yongfang Yuan, Rong Wang, Yanqiu Gu, Fuxing Song, Bin Wu, Bin Wu, Jing Wang, Rong Wang, Jing Wang and Panpan Chen. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.